Altered activity of plasma hemopexin in patients with minimal change disease in relapse

Pediatric Nephrology

Volumn 20, Issue 10, 2005, Pages 1410-1415

  Bakker, Winston W ^a   van Dael, Catharina M L ^a   Pierik, Leonie J W M ^a   van Wijk, Joanna A E ^b   Nauta, Jeroen ^c   Borghuis, Theo ^a   Kapojos, Jola J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Hemopexin; Minimal change disease; Nephrotic syndrome; Proteinuria

Indexed keywords

HEMOPEXIN; PROTEINASE;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IN VITRO STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MINIMAL CHANGE DISEASE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; REMISSION; URINALYSIS; WESTERN BLOTTING;

ADOLESCENT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; ELECTROPHORESIS; FEMALE; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMOPEXIN; HUMANS; MALE; NEPHROSIS, LIPOID; PEPTIDE HYDROLASES; PROTEINURIA; RECURRENCE; REMISSION INDUCTION;

EID: 26044451263     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1936-3     Document Type: Article

References (24)

1. Mason PD (2003) Minimal change disease and primary focal segmental glomerulosclerosis. In: Johnson RJ, Freehally J (eds) Comprehensive clinical nephrology, 2nd edn. Mosby, New York, pp 271-283
2. Sahali D, Pawlak A, Valanciute A, Grimbert P, Lang P, Remy P, Bensman A, Guellen G (2002) A novel approach to investigation of the pathogenesis of active minimal-change nephritic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13:1238-1247 11961011
3. Van den Berg JG, Nauta J, Aten J, Claessen N, Stordeur P, Florquin S, Davin JCMA, Weening JJ (2002) A possible role of IL-10 in the pathogenesis of minimal change nephrotic syndrome. J Am Soc Nephrol 13:349A
4. Ian CI, Chen A, Sum GH, Yu DS, Yen CY, Chen JS, Lin YF (2003) Recurrent minimal change disease post-allograft renal transplant Transplant Proc 35:2888-2890
5. Savin VJ (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347-362 8465812
6. Garin DH (2000) Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 14:872-878 10.1007/ s004679900269
7. Glassock RJ (2003) Circulating permeability factors in nephrotic syndrome: A fresh look at an old problem J Am Soc Nephrol 14:541-543
8. Cheung PK, Stulp B, Immenschuh S, Borghuis T, BallerJF, BakkerWW (1999) Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 10:1700-1708 10446937
9. Cheung PK, Klok PA, Baller JF, Bakker WW (2000) Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 57:1512-1520 10.1046/j.1523-1755.2000.00996.x
10. Kuzelova K, Mrhalova M, Hrkal Z (1997) Kinetics of heme interaction with heme-binding proteins: The effect of heme aggregation state. Biochim Biophys Acta 1336:497-501 9367177
11. Vincent SH, Grady RW, Shaklai N, Snider JM, Muller-Eberhard U (1988) The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys 265:539-550 10.1016/0003-9861(88)90159-2
12. Kamboh MI, Bunker CH, Nwankwo MU, Ferrell RE (1993) Hemopexin: A unique genetic polymorphism in populations of African ancestry. Hum Biol 65:655-660 8406412
13. Kamboh MI, Ferrell RE (1987) Genetic studies of low-abundance human plasma proteins. VI. Polymorphism of hemopexin. Am J Hum Genet 41:645-653 3661561
14. Gutteridge JM (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819-1828 7497639
15. Immenschuh S, Nagae Y, Satoh H, Baumann H, Muller-Eberhard U (1994) The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms. J Biol Chem 269:12654-12661 8175675
16. Immenschuh S, Song DX, Satoh H, Muller-Eberhard U (1995) The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun 207:202-208 10.1006/bbrc.1995.1173
17. Kapojos JJ, Poelstra K, Borghuis T, Banas B, Bakker WW (2004) Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cells. Nephron Physiol 96:1-10 10.1159/000075574
18. Bakker WW, Kapojos JJ, van den Berg A, Harmsen MC, Klok PA, Borghuis T (2002) Acute leakage of plasma proteins induced by unilateral perfusion of recombinant hemopexin (r-Hx) into the rat kidney. J Am Soc Nephrol 13:664A
19. Bakker WW, Borghuis T, Harmsen MC, van den Berg A, Kema IP, Niezen KE, Kapojos JJ (2004) Protease activity of plasma hemopexin. Kidney Int (in press)
20. Bakker WW, Baller JFW, van Luijk WHJ (1988) Increased vasoactivity and enhanced turnover of a kallikrein-like molecule in plasma from subjects with minimal change disease in relapse versus remission. Contrib Nephrol 67:31-36 3208532
21. Orasenneau J, Douet P, Massaoubre C, Lustenberger P, Bernard S (1989) An improved pyrogallol red molybdate method for determining total urinary protein. Clin Chem 35:2233-2236 2582622
22. Savin VJ, Sharma R, Lovell HV, Welling DJ (1992) Measurement of albumin reflection coefficient using isolated rat glomeruli. J Am Soc Nephrol 3:1260-1269 1477322
23. Carraro M, Zennaro C, Artero M, Cardiano G, Ghiggeri GM, Musante L, Sirch C, Bruschi M, Faccini L (2004) The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 19:1969-1975 10.1093/ndt/gfh343
24. Kapojos JJ, van den Berg A, van Goor H, Te Loo MWM, Poelstra K, Borghuis T, Bakker WW (2003) Production of hemopexin by TNFα stimulated human mesangium cells. Kidney Int 63:1681-1686 10.1046/ j.1523-1755.2003.00907.x